New drug for Duchenne muscular dystrophy clears phase 1 clinical trial testing in boys
Medication targets NF-κB, a key link between loss of dystrophin and disease progression Amsterdam, February 21, 2019 - Patients with Duchenne muscular dystrophy (DMD) have...










